ETV2 Overexpression Promotes Efficient Differentiation of Pluripotent Stem Cells to Endothelial Cells
Biotechnology and Bioengineering · 2025-07 · 122 (7) · 1914-1928
DOI: 10.1002/bit.28979 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2025-03-25. Written by Yunfeng Ding and 7 co-authors. Institution: Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA. Major MEDLINE topics: Cell Differentiation, Endothelial Cells, Transcription Factors, Pluripotent Stem Cells. Cited 13 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: NINDS NIH HHS, NHLBI NIH HHS, This work was supported by the National Institutes of Health grant numbers (HL154254, NS107461, NS109486) and the National Science Foundation (grant EEC-164803….
Abstract (original language)
Differentiating endothelial cells (ECs) from human pluripotent stem cells (hPSCs) typically takes 2 weeks and requires parameter optimization. Overexpression of cell type‐specific transcription factors in hPSCs has shown efficient differentiation into various cell types. ETV2, a crucial transcription factor for endothelial fate, can be overexpressed in hPSCs to induce rapid and facile EC differentiation (iETV2‐ECs). We developed a two‐stage strategy which involves differentiating inducible ETV2‐ overexpressing hPSCs in a basal induction medium during stage I and expanding them in an endothelial medium during stage II. By optimizing seeding density and medium composition, we achieved 99% pure CD31+ CD144+ iETV2‐ECs without cell sorting in 5 days. iETV2‐ECs demonstrated in vitro angiogenesis potential, LDL uptake, and cytokine response. Transcriptomic comparisons revealed similar gene expression profiles between iETV2‐ECs and traditionally differentiated ECs. Additionally, iETV2‐ECs responded to Wnt signaling agonist and TGFβ inhibitor to acquire brain EC phenotypes, making them a scalable EC source for applications including blood‐brain barrier modeling.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Neurological Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Funding
- NINDS NIH HHS
- NHLBI NIH HHS
- This work was supported by the National Institutes of Health grant numbers (HL154254, NS107461, NS109486) and the National Science Foundation (grant EEC-164803…
- National Science Foundation
Cite
APA
Ding, Y., Tamhankar, S., Du, F., Christopherson, T., Schlueter, N., Cohen, J. R., Shusta, E. V., & Palecek, S. P. (2025). ETV2 Overexpression Promotes Efficient Differentiation of Pluripotent Stem Cells to Endothelial Cells. Biotechnology and Bioengineering, 122(7), 1914-1928. https://doi.org/10.1002/bit.28979
Vancouver
Ding Y, Tamhankar S, Du F, Christopherson T, Schlueter N, Cohen JR, et al. ETV2 Overexpression Promotes Efficient Differentiation of Pluripotent Stem Cells to Endothelial Cells. Biotechnology and Bioengineering. 2025;122(7):1914-1928. doi:10.1002/bit.28979
BibTeX
@article{Ding2025,
author = {Ding, Yunfeng and Tamhankar, Soniya and Du, Feifan and Christopherson, Tessa and Schlueter, Nate and Cohen, Jenna R and Shusta, Eric V and Palecek, Sean P},
title = {ETV2 Overexpression Promotes Efficient Differentiation of Pluripotent Stem Cells to Endothelial Cells},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {7},
pages = {1914--1928},
doi = {10.1002/bit.28979}
}
EUVIMED